This is the preview version of the Wisconsin State Legislature site.
Please see http://docs.legis.wisconsin.gov for the production version.
Statement of Scope
CONTROLLED SUBSTANCES BOARD
Rule No.:
CSB 4
Relating to:
Monitored Prescription Drug History Reports
Rule Type:
Permanent
1. Finding/nature of emergency (Emergency Rule only): N/A
2. Detailed description of the objective of the proposed rule:
The objective of the proposed rule is to amend CSB 4.11 to allow a person authorized by a patient to request monitored prescription drug history reports about that same patient via mail.
3. Description of the existing policies relevant to the rule, new policies proposed to be included in the rule, and an analysis of policy alternatives:
Wisconsin Administrative Code Chapter CSB 4 currently outlines requirements for methods of obtaining monitored prescription drug history reports. Patients are allowed to request their own history reports either in person at the Department of Safety and Professional Services or via a mailed request on a form provided by the Board. A person authorized by the patient may only request copies of those same reports in person. Without making changes under the proposed rule, a person authorized by the patient will continue to only be able to make such requests in person at the Department.
4. Detailed explanation of statutory authority for the rule (including the statutory citation and language):
961.385 (2) (c) states that the board shall establish by rule and have the prescription drug monitoring program “specify the persons whom a record may be disclosed and the circumstances under which the disclosure may occur. Except as otherwise provided under this section, the rule promulgated under this paragraph shall comply with s. 146.82.
5. Estimate of amount of time that state employees will spend developing the rule and of other resources necessary to develop the rule: 60 hours
6. List with description of all entities that may be affected by the proposed rule:
Healthcare patients who have been prescribed monitored prescription drugs in Wisconsin and their authorized representatives.
7. Summary and preliminary comparison with any existing or proposed federal regulation that is intended to address the activities to be regulated by the proposed rule: None.
8. Anticipated economic impact of implementing the rule (note if the rule is likely to have a significant economic impact on small businesses):
None to minimal. It is not likely to have a significant economic impact on small businesses.
Contact Person: Nilajah Hardin, (608) 267-7139, DSPSAdminRules@wisconsin.gov
Loading...
Loading...
Links to Admin. Code and Statutes in this Register are to current versions, which may not be the version that was referred to in the original published document.